Kymeta & Airbus in Peru to demonstrate ‘SmartBus’ satellite links
Kymeta Corp., the Redmond, Wash.-based company backed by Microsoft co-founder Bill Gates and other investors, has demonstrated the performance of its flat-panel satellite antennas in an unlikely setting: on top of buses traveling throughout Peru.…
Off-the-shelf CAR-T and gene-editing player Precision Bio files $100M IPO
Precision BioSciences is looking to raise up to $100 million in an IPO just a few months after raising $110 million in a series B and bagging a hepatitis B alliance with Gilead. The Durham, North…
PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452
PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Presentation at the American College of Cardiology’s 68th Annual Scientific Session Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused…
String of ions may out-compute best quantum computers
New ion-based quantum computer debuts by computing the ground state of water. CHRIS LEE – 2/26/2019, 10:19 AM [Originally posted on Ars Technica] Usually, I reflexively delete press releases. This one was no different, but as the…
2019 Edward Novitski Prize awarded to Joseph Heitman
Joseph Heitman, MD, PhD of Duke University is the recipient of the 2019 Genetics Society of America (GSA) Edward Novitski Prize. Heitman is honored for his work on human fungal pathogens and for identifying the molecular targets of…
Duke Among Top 10 for Federal Medical Research Funding
Duke University received $384.6 million last year from the National Institutes of Health to advance medical research, ranking 9th in the country among universities, research institutions and teaching hospitals that are awarded the taxpayer-based research…
PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452
PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452
Duke-linked crop science startup Avalo raises $500K, looks for another $600K
DURHAM – Avalo, a Durham-based startup with ties to Duke University, has raised an additional $500,000 from two investors, according to an SEC filing. The company describes itself as “generating crop resilience through gene discovery for a…